» Articles » PMID: 21461130

Measurements of Radiation-Induced Skin Changes in Breast-Cancer Radiation Therapy Using Ultrasonic Imaging

Overview
Date 2011 Sep 28
PMID 21461130
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Skin injury is a common side effect of breast-cancer radiation therapy. Although physicians often observe skin toxicity, quantifying its severity remains a challenge. We present a novel quantitative ultrasonic technique to evaluate skin changes associated with radiotherapy. An in vivo study with twelve breast-cancer patients was conducted. All patients received a standard course of post-surgery radiation therapy. Each patient received ultrasound scans to the irradiated breast and the untreated (contra-lateral) breast. Radio-frequency (RF) backscatter signals and B-mode images were acquired simultaneously. To quantify the severity of skin injury, two metrics were calculated from the RF signals: skin thickness and Pearson correlation coefficient of the subcutaneous layer. Comparing to the non-irradiated skin, the average thickness of the irradiated skin increased by 40% (p=0.005) and the average correlation coefficient of the irradiated hypodermis decreased by 35% (p=0.02). This study demonstrates the feasibility of using a non-invasive ultrasonic technique to detect and quantify radiation-induced skin changes.

Citing Articles

Ultrasonographic Evaluation of Skin Toxicity Following Radiotherapy of Breast Cancer: A Systematic Review.

Hussein F, Manan H, Mustapha A, Sidek K, Yahya N Int J Environ Res Public Health. 2022; 19(20).

PMID: 36294025 PMC: 9603505. DOI: 10.3390/ijerph192013439.


A Comprehensive Prospective Comparison of Acute Skin Toxicity after Hypofractionated and Normofractionated Radiation Therapy in Breast Cancer.

Borm K, Kleine Vennekate J, Vagedes J, Islam M, Duma M, Loos M Cancers (Basel). 2021; 13(22).

PMID: 34830981 PMC: 8616262. DOI: 10.3390/cancers13225826.


Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound.

Landoni V, Giordano C, Marsella A, Saracino B, Petrongari M, Ferraro A J Exp Clin Cancer Res. 2014; 32:80.

PMID: 24423027 PMC: 4029440. DOI: 10.1186/1756-9966-32-80.


Spectrophotometer and ultrasound evaluation of late toxicity following breast-cancer radiotherapy.

Yoshida E, Chen H, Torres M, Curran W, Liu T Med Phys. 2011; 38(10):5747-55.

PMID: 21992389 PMC: 3203129. DOI: 10.1118/1.3633942.


Reliability of quantitative ultrasonic assessment of normal-tissue toxicity in breast cancer radiotherapy.

Yoshida E, Chen H, Torres M, Andic F, Liu H, Chen Z Int J Radiat Oncol Biol Phys. 2011; 82(2):724-31.

PMID: 21435799 PMC: 3156354. DOI: 10.1016/j.ijrobp.2010.12.066.


References
1.
Archambeau J, Pezner R, Wasserman T . Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995; 31(5):1171-85. DOI: 10.1016/0360-3016(94)00423-I. View

2.
Dische S, WARBURTON M, Jones D, Lartigau E . The recording of morbidity related to radiotherapy. Radiother Oncol. 1989; 16(2):103-8. DOI: 10.1016/0167-8140(89)90026-1. View

3.
Back M, Ahern V, Delaney G, Graham P, Steigler A, Wratten C . Absence of adverse early quality of life outcomes of radiation therapy in breast conservation therapy for early breast cancer. Australas Radiol. 2005; 49(1):39-43. DOI: 10.1111/j.1440-1673.2005.01392.x. View

4.
Warszawski A, Rottinger E, Vogel R, Warszawski N . 20 MHz ultrasonic imaging for quantitative assessment and documentation of early and late postradiation skin reactions in breast cancer patients. Radiother Oncol. 1998; 47(3):241-7. DOI: 10.1016/s0167-8140(97)00201-6. View

5.
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A . Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347(16):1227-32. DOI: 10.1056/NEJMoa020989. View